The National Health Service (Primary Medical Services and Primary Dental Services) (Wales) (Amendment and Transitional Provision) Regulations 2016 No. 90 (W. 43)

PART 3 Amendment of the GMS Prescription of Drugs Regulations

Amendment of Schedule 2 to the GMS Prescription of Drugs Regulations

9.  In Schedule 2 to the GMS Prescription of Drugs Regulations (drugs or medicines to be ordered only in certain circumstances)—

(a) in column 1 of the table (drugs) in the entry relating to drugs for the treatment of erectile dysfunction—

(i) omit “Apomorphine Hydrochloride”, “Moxisylyte Hydrochloride” and “Thymoxamine Hydrochloride”; and

(ii) after “Alprostadil” insert “Avanafil”;

(b) in column 2 of the table (patient) in the entry relating to the drug Oseltamivir (Tamiflu) for the treatment of influenza omit the wording “who is aged 1 year or over and” in each place it appears; and

(c) at the end of the table in the interpretation provision—

(i) omit the definitions of “at-risk” and “child”; and

(ii) in the appropriate alphabetical order, insert—

• ““at-risk” means in relation to a patient, a patient who—

(a) has chronic respiratory disease (including asthma and chronic obstructive pulmonary disease);

(b) has significant cardiovascular disease, excluding a patient who has hypertension only;

(c) has chronic renal disease;

(d) is immunocompromised;

(e) has diabetes mellitus;

(f) has chronic liver disease; or

(g) has chronic neurological disease;”.